Cargando…
Value of faecal exfoliated cells in colorectal tumour screening using SDC2 methylation test
BACKGROUND: This study aimed to evaluate the diagnostic value of a non-invasive methylation gene test in clinical colorectal tumour screening. METHOD: The quantitative methylation-specific PCR technique was used to detect faecal methylated syndecan-2 (mSDC2) in patients who received the screening of...
Autores principales: | Liu, Yan-Mei, Peng, Lei, Chen, Chen, Zhou, Peng, Cheng, Bin, Luo, Ying, Zhou, Mei-Fang, Xuan, Shu-Xia, Lin, Jin-Duan, Yin, Wei-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547446/ https://www.ncbi.nlm.nih.gov/pubmed/37783044 http://dx.doi.org/10.1080/07853890.2023.2261111 |
Ejemplares similares
-
Methylation of SDC2/TFPI2 and Its Diagnostic Value in Colorectal Tumorous Lesions
por: Zhang, Lianglu, et al.
Publicado: (2021) -
Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms
por: Zeng, Tao, et al.
Publicado: (2023) -
Value of Methylation Status of RPRM, SDC2, and TCF4 Genes in Plasma for Gastric Adenocarcinoma Screening
por: Guo, Jianghong, et al.
Publicado: (2023) -
The methylation of SDC2 and TFPI2 defined three methylator phenotypes of colorectal cancer
por: Lei, Ruixue, et al.
Publicado: (2022) -
Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer
por: Su, Wei-Chih, et al.
Publicado: (2021)